The ataxia telangiectasia mutated (<i>ATM</i>) gene, coding a serine/threonine kinase involved in the early stages of the homologous recombination (HR) mechanism, is one of the most altered genes in GBC. The gene discussed is MARK2; the disease is Telangiectasia.